中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
16期
493-493,494
,共2页
静吸复合麻醉%颅内手术患者%麻醉用量%不良反应
靜吸複閤痳醉%顱內手術患者%痳醉用量%不良反應
정흡복합마취%로내수술환자%마취용량%불량반응
Inhalation anesthesia%Intracranial surgery%Anesthetic dosage%Adverse reactions
目的探讨静吸复合麻醉对颅内手术患者麻醉用量及不良反应的影响。方法选取我院2012年1月至2012年12月采取静吸复合麻醉方式行颅内手术患者60例,随机分成A、B、C三组,分别给予患者不同麻醉用量,观察不同麻醉用量麻醉效果和不良反应情况。结果 A组不良反应3例,发生率为15.0%,B组9例(30.0%),C组21例(70.0%);A组和B组麻醉效果差异明显(P<0.05),B组和C组麻醉效果比较无显著差异(P>0.05)。结论对于采取静吸复合麻醉方式行颅内手术患者,2~3μg/mL血浆靶浓度丙泊酚复合4~6ng/mL血浆靶浓度瑞芬太尼与3~5μg/ml丙泊酚复合6~8ng/mL血浆靶浓度瑞芬太尼麻醉效果与无明显差异,不良反应较少,值得进一步研究和临床推广应用。
目的探討靜吸複閤痳醉對顱內手術患者痳醉用量及不良反應的影響。方法選取我院2012年1月至2012年12月採取靜吸複閤痳醉方式行顱內手術患者60例,隨機分成A、B、C三組,分彆給予患者不同痳醉用量,觀察不同痳醉用量痳醉效果和不良反應情況。結果 A組不良反應3例,髮生率為15.0%,B組9例(30.0%),C組21例(70.0%);A組和B組痳醉效果差異明顯(P<0.05),B組和C組痳醉效果比較無顯著差異(P>0.05)。結論對于採取靜吸複閤痳醉方式行顱內手術患者,2~3μg/mL血漿靶濃度丙泊酚複閤4~6ng/mL血漿靶濃度瑞芬太尼與3~5μg/ml丙泊酚複閤6~8ng/mL血漿靶濃度瑞芬太尼痳醉效果與無明顯差異,不良反應較少,值得進一步研究和臨床推廣應用。
목적탐토정흡복합마취대로내수술환자마취용량급불량반응적영향。방법선취아원2012년1월지2012년12월채취정흡복합마취방식행로내수술환자60례,수궤분성A、B、C삼조,분별급여환자불동마취용량,관찰불동마취용량마취효과화불량반응정황。결과 A조불량반응3례,발생솔위15.0%,B조9례(30.0%),C조21례(70.0%);A조화B조마취효과차이명현(P<0.05),B조화C조마취효과비교무현저차이(P>0.05)。결론대우채취정흡복합마취방식행로내수술환자,2~3μg/mL혈장파농도병박분복합4~6ng/mL혈장파농도서분태니여3~5μg/ml병박분복합6~8ng/mL혈장파농도서분태니마취효과여무명현차이,불량반응교소,치득진일보연구화림상추엄응용。
?Objective?To study the static absorption dosage of compound anesthesia in patients with intracranial surgery anesthesia and the impact of adverse reactions. Methods From January 2012- December 2012 static absorption compound anesthesia ways line of 60 patients with intracranial surgery, were randomly divided into A, B, C three groups and were given different dosage of anesthetic patients, observe the different dosage of anesthetic effects and adverse reactions. Results Incidence of adverse reactions for group A, group B 9 cases (30.0%), 21 cases of group C (70.0%); Clear difference anesthetic effect in group A and group B (P<0.05), group B and group C anesthesia effect is no significant difference (P>0.05). Conclusion To adopt static absorption line compound anesthesia of intracranial surgery patients, 2~3 μg/mL plasma concentration of propofol target compound 4, 6 ng/mL target plasma concentration, fentanyl and 3~5 μg/mL propofol compound 6-8 ng/mL, fentanyl anesthesia target plasma concentration effect and no obvious difference, with less adverse reactions, worthy of further research and clinical application.